Nektar Therapeutics (NKTR) stock surges as Oppenheimer upgrades ahead of key mid-stage trial readout for an eczema drug. Read ...

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report) yesterday and set a price target ...

Jack Quaid is amazed at how the Oppenheimer cast still remains connected after nearly two years after the film first ...

From checking in amid the L.A. fires to supporting each other's careers, Quaid says the star-studded cast still chats ...

Christopher Nolan doesn't need an image to maintain; from Following (1998) to Oppenheimer (2023), fans know what's in store ...

In a report released on March 14, Matthew Biegler from Oppenheimer reiterated a Buy rating on Allogene Therapeutics (ALLO – Research Report), ...

A fresh set of headlines may have given investors fresh reasons to sell Tesla, among them competitive news out of China and ...

David Bohm was a brilliant physicist. In the latter part of World War II, when he was just a graduate student, his PhD ...

EQT (NYSE:EQT – Get Free Report) had its target price raised by Citigroup from $51.00 to $60.00 in a research report issued ...

Investing.com - Tesla’s ability to replace some of its consumer base driven away by the political activities of CEO Elon Musk will likely influence the near-term performance of the stock, according to ...

Remembering Pat, a good friend from Omaha, Neb.

Leaders from Pennant Group, Inc. (Nasdaq: PNTG), the parent company of a network of home health, hospice, and senior living ...